FindTrial
Sign In

New surgical treatment of Glaucoma trial

A prospective trial to assess results of trabeculectomy by using ologen as continuum from sub-scleral space to sub-conjunctival space

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/02/017525
Enrollment
20
Registered
2019-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H409- Unspecified glaucoma

Interventions

Intervention1: Glaucoma surgery: Using Ologen as continuum from subscleral space to subconjuctival space during trabeculectomy. Results are evaluated for 3 months after surgery. Control Intervention1:

Sponsors

Centre for Sight
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients with IOP not controlled on medication b) Patients willing to undergo trab as an alternative to life-long medication c) Patients not tolerating the anti-glaucoma medication

Exclusion criteria

Exclusion criteria: a) Any co-morbidity which contra-indicates surgery b) Patients having neo-vascular glaucoma

Design outcomes

Primary

MeasureTime frame
Percentage of subjects having IOP of less than 20 mm Hg without or with reduced medication after 3months of surgery.Timepoint: Percentage of subjects having IOP of less than 20 mm Hg without or with reduced medication after 3months of surgery.—

Secondary

MeasureTime frame
Adverse eventTimepoint: Day 1,3, 10, 30, 90—

Countries

India

Contacts

Public ContactDrRoop

Centre for Sight

roopfamous@gmail.com9897077115

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026